HerRx Weight Loss includes compounded products that have not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs. Metformin, topiramate, bupropion, and naltrexone are commonly used by obesity specialists off-label to promote weight loss. PCompounded semaglutide, including Hims & Hers’ product (pictured above), is not approved or evaluated for safety, efficacy, or quality by FDA.

Wegovy® (semaglutide), Ozempic® (semaglutide), Mounjaro® (tirzepatide), and Zepbound® (tirzepatide) are not compounded. Mounjaro® and Ozempic® are FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare provider's discretion. Wegovy® and Zepbound® are FDA-approved for weight loss.

A healthcare provider may prescribe a compounded drug if determined that it is medically appropriate and necessary for you. Prescription products require an online consultation with a licensed provider who will determine if a prescription is appropriate.

*Based on studies of topical and oral minoxidil. Hair Blends are compounded products and have not been approved by the FDA. The FDA does not verfiy the safety or effectiveness of compounded drugs. Prescription products require an online consultation with a licensed provider who will determine if a prescription is appropriate.